Genome-wide association analysis identifies three new breast cancer susceptibility loci

M Ghoussaini, O Fletcher, K Michailidou, C Turnbull, Marjanka K Schmidt, E Dicks, J Dennis, Q (Qing) Wang, MK Humphreys, C Luccarini, C Baynes, D Conroy, M Maranian, S (Shahana) Ahmed, K Driver, N Johnson, N Orr, ID Silva, Q Waisfisz, H Meijers-HeijboerAndré Uitterlinden, Fernando Rivadeneira, P Hall, K Czene, A Irwanto, JJ Liu, H Nevanlinna, K Aittomaki, C Blomqvist, A Meindl, RK Schmutzler, B Muller-Myhsok, P Lichtner, J Chang-Claude, R Hein, S Nickels, D Flesch-Janys, H Tsimiklis, E Makalic, D Schmidt, M Bui, JL Hopper, C Apicella, DJ Park, M Southey, DJ Hunter, SJ Chanock, A Broeks, S Verhoef, FBL Hogervorst, PA Fasching, MP Lux, MW Beckmann, AB Ekici, E Sawyer, I Tomlinson, M Kerin, F Marme, A Schneeweiss, C Sohn, B Burwinkel, P Guenal, T Truong, E Cordina-Duverger, F Menegaux, SE Bojesen, BG Nordestgaard, SF Nielsen, H Flyger, RL Milne, MR Alonso, A Gonzalez-Neira, J Benitez, H Anton-Culver, A Ziogas, L Bernstein, CC Dur, H Brenner, H Muller, V Arndt, C Stegmaier, C Justenhoven, H Brauch, T Bruning, S Wang-Gohrke, U Eilber, T Dork, P Schurmann, M Bremer, P Hillemanns, NV Bogdanova, NN Antonenkova, YI Rogov, JH Karstens, M Bermisheva, D Prokofieva, E Khusnutdinova, A Lindblom, S Margolin, A Mannermaa, V Kataja, VM Kosma, JM Hartikainen, D Lambrechts, BT Yesilyurt, G Floris, K Leunen, S Manoukian, B Bonanni, S Fortuzzi, P Peterlongo, FJ Couch, XS Wang, K Stevens, A Lee, GG Giles, L Baglietto, G Severi, C McLean, GG Alnaes, V Kristensen, AL Borrensen-Dale, EM John, A Miron, R Winqvist, K Pylkas, A Jukkola-Vuorinen, S Kauppila, IL Andrulis, G Glendon, AM Mulligan, P Devilee, CJ van Asperen, RAEM Tollenaar, Caroline Seynaeve, JD Figueroa, M Garcia-Closas, L Brinton, J Lissowska, Maartje Hooning, Antoinette Hollestelle, Rogier Oldenburg, Ans van den Ouweland, A Cox, MWR Reed, M Shah, A Jakubowska, J Lubinski, K Jaworska, K Durda, M Jones, M Schoemaker, A Ashworth, A Swerdlow, J Beesley, XQ Chen, KR Muir, A Lophatananon, S Rattanamongkongul, A Chaiwerawattana, D Kang, KY Yoo, DY Noh, CY Shen, JC Yu, PE Wu, CN Hsiung, A Perkins, R Swann, L Velentzis, DM Eccles, WJ Tapper, SM Gerty, NJ Graham, BAJ Ponder, G Chenevix-Trench, PDP Pharoah, M Lathrop, AM Dunning, N Rahman, J Peto, DF Easton

Research output: Contribution to journalArticleAcademicpeer-review

239 Citations (Scopus)

Abstract

Breast cancer is the most common cancer among women. To date, 22 common breast cancer susceptibility loci have been identified accounting for similar to 8% of the heritability of the disease. We attempted to replicate 72 promising associations from two independent genome-wide association studies (GWAS) in similar to 70,000 cases and similar to 68,000 controls from 41 case-control studies and 9 breast cancer GWAS. We identified three new breast cancer risk loci at 12p11 (rs10771399; P = 2.7 x 10(-35)), 12q24 (rs1292011; P = 4.3 x 10(-19)) and 21q21 (rs2823093; P = 1.1 x 10(-12)). rs10771399 was associated with similar relative risks for both estrogen receptor (ER)-negative and ER-positive breast cancer, whereas the other two loci were associated only with ER-positive disease. Two of the loci lie in regions that contain strong plausible candidate genes: PTHLH (12p11) has a crucial role in mammary gland development and the establishment of bone metastasis in breast cancer, and NRIP1 (21q21) encodes an ER cofactor and has a role in the regulation of breast cancer cell growth.
Original languageUndefined/Unknown
Pages (from-to)312-U120
JournalNature Genetics
Volume44
Issue number3
DOIs
Publication statusPublished - 2012

Research programs

  • EMC MGC-02-96-01
  • EMC MM-01-39-09-A
  • EMC MM-03-86-01

Cite this